Crossmark Global Holdings’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $65.6K | Hold |
14,205
| – | – | ﹤0.01% | 1257 |
|
|
2026
Q1 | $65.8K | Sell |
14,205
-130
| -0.9% | -$678 | ﹤0.01% | 1230 |
|
|
2025
Q4 | $71.7K | Buy |
14,335
+260
| +2% | +$1.35K | ﹤0.01% | 1219 |
|
|
2025
Q3 | $71.4K | Sell |
14,075
-68
| -0.5% | -$300 | ﹤0.01% | 1281 |
|
|
2025
Q2 | $61K | Buy |
14,143
+1,676
| +13% | +$8.28K | ﹤0.01% | 1316 |
|
|
2025
Q1 | $75.2K | Buy |
12,467
+54
| +0.4% | +$273 | ﹤0.01% | 1307 |
|
|
2024
Q4 | $49K | Sell |
12,413
-70
| -0.6% | -$314 | ﹤0.01% | 1246 |
|
|
2024
Q3 | $73K | Hold |
12,483
| – | – | ﹤0.01% | 1274 |
|
|
2024
Q2 | $54K | Sell |
12,483
-124
| -1% | -$594 | ﹤0.01% | 1289 |
|
|
2024
Q1 | $60K | Sell |
12,607
-1,747
| -12% | -$6.69K | ﹤0.01% | 1322 |
|
|
2023
Q4 | $70K | Sell |
14,354
-826
| -5% | -$4.04K | ﹤0.01% | 1292 |
|
|
2023
Q3 | $81K | Hold |
15,180
| – | – | ﹤0.01% | 1247 |
|
|
2023
Q2 | $152K | Hold |
15,180
| – | – | ﹤0.01% | 1270 |
|
|
2023
Q1 | $125K | Buy |
15,180
+231
| +2% | +$2.55K | ﹤0.01% | 1271 |
|
|
2022
Q4 | $167K | Sell |
14,949
-535
| -3% | -$6.22K | ﹤0.01% | 1216 |
|
|
2022
Q3 | $183K | Sell |
15,484
-680
| -4% | -$10.3K | 0.01% | 1184 |
|
|
2022
Q2 | $247K | Buy |
16,164
+460
| +3% | +$8.28K | 0.01% | 1126 |
|
|
2022
Q1 | $332K | Buy |
15,704
+1,200
| +8% | +$25.9K | 0.01% | 1094 |
|
|
2021
Q4 | $343K | Sell |
14,504
-42,216
| -74% | -$904K | 0.01% | 1087 |
|
|
2021
Q3 | $1.14M | Sell |
56,720
-264,274
| -82% | -$5.42M | 0.03% | 575 |
|
|
2021
Q2 | $6.45M | Buy |
320,994
+19,298
| +6% | +$413K | 0.15% | 156 |
|
|
2021
Q1 | $6.42M | Sell |
301,696
-1,036
| -0.3% | -$22.3K | 0.16% | 155 |
|
|
2020
Q4 | $6.6M | Buy |
302,732
+260,868
| +623% | +$5.08M | 0.17% | 142 |
|
|
2020
Q3 | $738K | Hold |
41,864
| – | – | 0.02% | 625 |
|
|
2020
Q2 | $787K | Buy |
41,864
+1,224
| +3% | +$21.7K | 0.02% | 604 |
|
|
2020
Q1 | $703K | Buy |
40,640
+50
| +0.1% | +$1.04K | 0.03% | 556 |
|
|
2019
Q4 | $857K | Sell |
40,590
-1,180
| -3% | -$23.9K | 0.02% | 603 |
|
|
2019
Q3 | $817K | Sell |
41,770
-530
| -1% | -$9.74K | 0.02% | 593 |
|
|
2019
Q2 | $738K | Buy |
42,300
+210
| +0.5% | +$3.78K | 0.02% | 643 |
|
|
2019
Q1 | $779K | Sell |
42,090
-370
| -0.9% | -$6.6K | 0.02% | 625 |
|
|
2018
Q4 | $683K | Buy |
42,460
+10,810
| +34% | +$171K | 0.02% | 640 |
|
|
2018
Q3 | $472K | Buy |
31,650
+450
| +1% | +$6.56K | 0.01% | 992 |
|
|
2018
Q2 | $438K | Sell |
31,200
-620
| -2% | -$8.21K | 0.01% | 1035 |
|
|
2018
Q1 | $414K | Sell |
31,820
-780
| -2% | -$9.98K | 0.01% | 1046 |
|
|
2017
Q4 | $449K | Sell |
32,600
-1,310
| -4% | -$17.7K | 0.01% | 1076 |
|
|
2017
Q3 | $445K | Buy |
+33,910
| New | +$437K | 0.01% | 1034 |
|
|
2016
Q3 | $445K | Buy |
+33,910
| New | +$513K | 0.01% | 1034 |
|
Other funds holding MPT
WAM
Crossmark Global Holdings's MPT Position: Q2 2026 in Review
Crossmark Global Holdings held its Medical Properties Trust (MPT) position steady in Q2 2026 at 14,205 shares worth $65.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1257.
Crossmark Global Holdings first reported a position in MPT in Q3 2016 and has held it in 37 quarters since. The position peaked at $6.6M in Q4 2020. 488 funds tracked by Wall St. Rank hold MPT as of Q2 2026.
- Crossmark Global Holdings held 14,205 shares of Medical Properties Trust worth $65.6K as of Q2 2026.
- Crossmark Global Holdings left its Medical Properties Trust share count unchanged in Q2 2026.
- Medical Properties Trust made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #1257 holding.
- Crossmark Global Holdings first reported a position in Medical Properties Trust in Q3 2016 and has held it in 37 quarters since.
- Crossmark Global Holdings's Medical Properties Trust position peaked at $6.6M in Q4 2020.
- 488 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.